Differences between a patient’s true normal range and the population-based reference interval can create problems for doctors ...

Genetic testing, which has expanded in recent years with advances in technology and the development of consumer products, is ...

Adding genetic testing to the evaluation of pediatric patients with neurodevelopmental disorders (NDD) resulted in more ...

The test used two synovial fluid biomarkers to accurately differentiate osteoarthritis from inflammatory arthritis, but its ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

GP practices are facing confusion over different approaches to asthma diagnosis set out in the QOF and in the new UK joint ...

Corvus Pharmaceuticals develops next-gen ITK inhibitors, with promising Phase 1 results. Read why CRVS stock can thrive in ...

The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP ...

Broad enrollment criteria appear to have scuttled the trial, which was designed to test whether ctDNA could identify patients ...

Special Report: Predictive cancer diagnostics company Rhythm Biosciences (ASX:RHY) is ending 2024 on a high reporting it had ...

Roche launches its cobas® Mass Spec solution, bringing mass spectrometry to the routine clinical lab Clinical mass ...